Monitoring gastric cancer progression with circulating tumour DNA. - Wikidata - awgldk - TriplyDB

Monitoring gastric cancer progression with circulating tumour DNA.

Monitoring gastric cancer progression with circulating tumour DNA.

http://www.wikidata.org/entity/Q42275485

about

Circulating biomarkers to monitor cancer progression and treatment Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer Circulating tumor DNA in hepatocellular carcinoma: trends and challenges New blood markers detection technology: A leap in the diagnosis of gastric cancer Emerging blood-based biomarkers for detection of gastric cancer Notes for developing a molecular test for the full characterization of circulating tumor cells Clinical applications of liquid biopsies in gastrointestinal oncology Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy Circulating Cell-Free Tumour DNA in the Management of Cancer.Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA.Circulating nucleic acids: An analysis of their occurrence in malignancies.Noninvasive genotyping and monitoring of anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer by capture-based next-generation sequencing.Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.Clinical Outcomes of TP53 Mutations in Cancers.Dynamic tracing for epidermal growth factor receptor mutations in urinary circulating DNA in gastric cancer patients.The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.Liquid biopsy provides new insights into gastric cancer.Mutation detection using plasma circulating tumor DNA (ctDNA) in a cohort of asymptomatic adults at increased risk for cancer.Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells.Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy Long non-coding RNAs involved in metastasis of gastric cancer

P2860

Q26745985-C61031F5-7965-47D6-9389-605FF8688DC6 Q26746010-1B213A16-6776-4C32-B9CC-96DA72326732 Q26749417-713AA96D-7D55-4B31-B01B-25D4E5BA7359 Q26774503-2E1ADB7C-D6EC-4545-8133-1FFA01E8E178 Q26778026-08DC40BC-968D-48B6-AB55-EED3F4E336CA Q26778913-D82AC0F5-4774-42F1-B5E2-9F4BFB854251 Q28073730-673F2CAA-3F4A-4583-B018-6920D5F0671A Q33866887-E041C866-E396-4AE8-867B-271357B8414C Q35814162-F0341029-C9C7-4B59-AAA5-E5CA28725101 Q35881722-380F5246-6614-46C0-B80E-1B74FCADD33F Q36219131-8F2BB416-F71B-4EF4-A941-DC29FD5E9B87 Q37593852-B807150C-4FD6-43ED-AF1B-943A48C0A471 Q37662209-83F6B2F5-EF49-45F4-85CA-D8B842CF5FC6 Q38770935-271D4931-30B5-4F6C-B3AE-8EA565C6D528 Q38906201-CA196504-5042-4B31-A5C0-C34E33F355DF Q38949788-78919AD6-FF16-4D05-AA4B-95925E9BDAB4 Q39183864-73DFDCE5-4806-4B0B-94CD-B3E2D62A786A Q48521971-3E2E984A-A8C7-4A84-B46E-A6C9D5A48AB0 Q52620413-1384F433-5FD5-403C-BA31-7B9D638037BB Q55004197-8A4F7AEC-A053-4E44-98F7-9BDC183D24F2 Q55070721-8A0368B3-25EC-4160-8914-E6EAA594D419 Q57147396-E33A7CAB-69B2-4F19-A56E-1648B8049821 Q58760411-43B4DEDB-9A9A-4F8D-9478-AB19E0C12657

P2860

Monitoring gastric cancer progression with circulating tumour DNA.

http://www.wikidata.org/entity/Q42275485

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Monitoring gastric cancer progression with circulating tumour DNA.

@en

Monitoring gastric cancer progression with circulating tumour DNA.

@nl

type

label

Monitoring gastric cancer progression with circulating tumour DNA.

@en

Monitoring gastric cancer progression with circulating tumour DNA.

@nl

prefLabel

Monitoring gastric cancer progression with circulating tumour DNA.

@en

Monitoring gastric cancer progression with circulating tumour DNA.

@nl

P1433

Q42275485-AF2CD1CB-94BC-4DA3-98CD-8E148A286D3D

P1476

Q42275485-E48C7D32-5AEA-480B-8F22-B1C3ABA19996

P2093

Q42275485-0629423F-07B0-480E-8AF3-CFA6585620C3

Q42275485-08F5A7B8-86B1-40F9-B1EE-9094837473B1

Q42275485-36944001-F625-42B9-9EA0-F991CF096FCC

Q42275485-389E45A7-4580-4042-BE40-587D4A843C6B

Q42275485-3992F488-52F1-435C-9C36-00C8D2318AD3

Q42275485-3C16ED4F-9864-49F5-84D0-CD27C32E869F

Q42275485-3D2E6424-4D37-4C4A-8B9C-A9B80483D1BD

Q42275485-4632C0CA-EC9A-4F6F-81CC-1F83AD3CB67E

Q42275485-5B51B179-09C4-43D2-863F-89810377D4B6

Q42275485-615A91EC-3AD4-4942-A947-BDCB596344B3

P2860

Q42275485-04EDD378-847D-42C3-80FC-0DB9EA449DB6

Q42275485-15DD4F46-17C3-4D81-91BB-DFFB62C8D9B1

Q42275485-24E48D78-DD65-416E-B477-415693A388B8

Q42275485-30EA4697-DF51-44C9-AA80-35266538E8B8

Q42275485-4348C950-0F9C-4563-A1E8-BF3934322CBD

Q42275485-65616458-19FA-47E6-982C-985F764E4355

Q42275485-78701A5A-9158-4D88-B042-C8656D9EB320

Q42275485-791A88D5-0ECC-4718-A97D-FAFEF3E48C52

Q42275485-8E9AEA26-D709-4310-A743-63D044710140

Q42275485-E9514C5D-02FA-4607-8BE2-7FF55CD5F709

P2888

Q42275485-E42BBEC1-22D2-45BF-ABD9-8F494C20C2C1

P304

Q42275485-AF59DE62-1E6E-4BD1-B928-A054B76D8140

P31

Q42275485-61EB2546-42C9-4D20-9AD4-6D4F4B5402C2

P356

Q42275485-720248FB-7404-433D-ACAF-0DC039CF28EC

P407

Q42275485-13FE6F01-0DC9-4B26-A723-F9E7B8B25CB7

P433

Q42275485-8DE10BFF-6302-4842-BF36-712CB002C91C

P478

Q42275485-6F322EB5-5D3B-4DA2-B7C0-2A0560BA073D

P577

Q42275485-7A8B1F57-2529-402C-A878-237473B840BB

P5875

Q42275485-509EEE64-4E5D-45E0-9B2B-1D3D1AC8F234

P6179

Q42275485-B7FD8C82-21A0-478C-8C54-06A11694C32A

P698

Q42275485-BA943EC2-1116-45AD-83C9-48CECF739F9D

P932

Q42275485-B2799375-C495-4BB3-A2EF-6697A7D9BA28

P356

P1433

British Journal of Cancer

P1476

Monitoring gastric cancer progression with circulating tumour DNA.

@en

P2093

H Miyata

http://www.w3.org/2001/XMLSchema#string

K Kato

http://www.w3.org/2001/XMLSchema#string

K Nakajima

http://www.w3.org/2001/XMLSchema#string

K Taniguchi

http://www.w3.org/2001/XMLSchema#string

M Mori

http://www.w3.org/2001/XMLSchema#string

M Yamasaki

http://www.w3.org/2001/XMLSchema#string

S Takiguchi

http://www.w3.org/2001/XMLSchema#string

T Hamakawa

http://www.w3.org/2001/XMLSchema#string

T Takahashi

http://www.w3.org/2001/XMLSchema#string

Y Doki

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Circulating mutant DNA to assess tumor dynamics

Analysis of circulating tumor DNA to monitor metastatic breast cancer

Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data.

Cell-free nucleic acids as biomarkers in cancer patients.

Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients.

Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.

Updating benchtop sequencing performance comparison.

MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis.

P2888

P304

352-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2014.609

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269414797

http://www.w3.org/2001/XMLSchema#string

P6179

1011062131

http://www.w3.org/2001/XMLSchema#string

P698

25490524

http://www.w3.org/2001/XMLSchema#string

P932

4453461

http://www.w3.org/2001/XMLSchema#string